(often sold as Covance CP or Covance 50) is a brand name for the prescription drug Losartan . Primary Uses: Treats high blood pressure (hypertension).
It is an Angiotensin II Receptor Blocker (ARB) that relaxes blood vessels to lower pressure and ease heart strain.
Covance was acquired by Labcorp in 2015 and officially rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development portion was spun off as an independent company named Fortrea . Key Services: COVANCE
Managing phases I–IV of drug development for pharmaceutical and biotech firms.
Reduces the risk of in patients with an enlarged heart. Protects kidney function in patients with Type 2 diabetes. (often sold as Covance CP or Covance 50)
Operating central laboratories for specimen testing and medical device verification.
Assisting companies with FDA filings and drug commercialization. Covance was acquired by Labcorp in 2015 and
Are you interested in through the company, or Overview of Covance Clinical Research and Drug Discovery